Neuronetics, Inc. (NASDAQ: STIM) revealed a significant development in mental healthcare, announcing that Evernorth Health ...

Cigna's Evernorth unit is expanding coverage for Neuronetics' therapy for depression to adolescents. | Cigna's Evernorth unit ...

The expansion is effective immediately, nearly one year after NeuroStar ® Advanced Therapy received FDA clearance as the first first-line add-on treatment for adolescents aged 15-21 with MDD. In the ...

Neuronetics (STIM) announced that Evernorth Health Services, a wholly owned subsidiary of The Cigna Group, has expanded its coverage of ...

Spending on GLP-1 drugs continues to rise, after outpacing trends among specialty drugs for the first time in 2023, according ...

Healthcare lease accounting insights: How two organizations got compliant and stay audit-ready all year long Healthcare ...

Vermont Business Magazine Evernorth closed Housing New England, Fund VI on March 19, 2025. This fund will provide equity to ...

March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, providers like Providence and Geisinger have appointed new C-suite leaders, and companies like ...

The trend isn’t expected to revert, at least in the next few years, amid sustained demand for GLP-1s for weight loss and as ...

(Reuters) -Healthcare conglomerate Cigna appointed Chief Financial Officer Brian Evanko to the newly created position of chief operating officer and promoted his deputy, Ann Dennison, to the top ...

“This decision by Cigna/Evernorth is a significant step forward for adolescent mental healthcare and reflects the momentum we have built with payors over the past year since NeuroStar first ...

The trend isn’t expected to revert, at least in the next few years, amid sustained demand for GLP-1s for weight loss and as the drugs become approved for more conditions, Evernorth said.